Takara Bio is working on the commercialization of its proprietary platform technology for biologics development.
In the gene medicine business, as an application field of our core technologies of genetic engineering technology and cell engineering technology, we develop the Ancillary materials discovery technology developed by our company, and develop, manufacture, and sell production aids for gene therapy materials.
- Development, manufacture, and sale of plasmids, viral vectors, and ancillary materials, including RetroNectin®, for manufacturing gene therapy products
- Applied development of CereAAV™, a brain/retina-tropic adeno-associated virus (AAV) vector, and SonuAAV™, an inner ear/muscle-tropic AAV vector
- 拡大
- RetroNectin®
